Woodland Hills-based Acelyrn Inc., which is creating immunology medicine, raised a minimum of $540 million in an preliminary public providing on the Nasdaq market on Might 5   Buying and selling underneath the image SLRN, Acelyrin supplied 30 million shares at $18 per share. On the shut of buying…